## Emergency Contraception: Drug of Choice in India **Key Point:** Levonorgestrel 1.5 mg as a single oral dose is the **first-line / drug of choice for emergency contraception in India** when presented within 72 hours of unprotected intercourse, as per Indian national guidelines and WHO recommendations for resource-limited settings. ### Why Levonorgestrel (Option D) is Correct - **Timing:** The patient presents at 18 hours — well within the optimal ≤72-hour window for levonorgestrel. - **Availability:** Levonorgestrel is widely available over-the-counter in India (e.g., i-Pill, Unwanted-72), making it the practical first-line choice. - **Safety:** No significant contraindications in women without hormonal method restrictions; the stem explicitly states no contraindications. - **Efficacy at 18 hours:** Approximately 85% effective in the 12–24-hour window — clinically excellent. - **Single-dose regimen (1.5 mg):** Preferred over the older two-dose schedule (0.75 mg × 2) for better compliance with equivalent efficacy (WHO EC Guidelines, 2012). ### Mechanism of Action Levonorgestrel is a synthetic progestin that prevents or delays ovulation primarily by suppressing the LH surge. It does **not** interrupt an established pregnancy. ### Efficacy Timeline | Time from intercourse | Efficacy | |---|---| | 0–12 hours | ~95% | | 12–24 hours | ~85% | | 24–72 hours | ~58% | ### Why the Other Options Are Less Appropriate Here | Agent | Issue | |---|---| | **Ulipristal acetate (A)** | Superior efficacy at 72–120 hrs; at 18 hrs, levonorgestrel is equally effective and is the established DOC in Indian/NEET context. Ulipristal is not widely available OTC in India. | | **Copper IUD (B)** | Most effective overall (>99%), but requires clinical insertion — not a pharmacological "drug of choice." | | **Mifepristone 10 mg daily × 3 days (C)** | **Incorrect dosing** — mifepristone for EC is given as a **single dose of 10 mg**, not daily for 3 days. This option is factually wrong and thus an invalid choice. | **Clinical Pearl:** Ulipristal acetate (selective progesterone receptor modulator, ≤120 hrs) has superior efficacy especially in the 72–120-hour window and in women with higher BMI. However, for NEET PG / INI-CET purposes and Indian clinical practice, **levonorgestrel remains the drug of choice** for EC within 72 hours, per Shaw's Textbook of Gynaecology and Indian national family planning guidelines. **High-Yield Mnemonic:** **LNG-EC** = **L**evonorgestrel **N**eeds to be **G**iven **E**arly and **C**onsistently (within 72 hours). > *Reference: Shaw's Textbook of Gynaecology, 17th ed.; WHO Emergency Contraception Fact Sheet, 2021; MoHFW India Family Planning Guidelines.*
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.